Leukocyte-Poor Platelet-Rich Plasma (PRP)

Available via Spartan Medical’s

Supporting Product Literature:

PRPs have the most published level I studies and meta-analysis supporting its use for some orthopedic applications.

  • The Selphyl proprietary gel separation technology resulted in the most consistent and reproducible PRP system in an independent comparison study from Stanford (Dragoo et al.).
  • Leukocyte poor and red blood cell free (Pure PRP) (Dragoo et al.).
  • Low blood draw (9-18ccs), short spin time (6 min), closed system preloaded with sodium citrate anticoagulant (no buffering required when using sodium citrate vs. ACD-A, Mishra et al.).
  • Selphyl has a long history of safety and efficacy; 4cc & 8cc PRP volumes with a 2-year shelf-life.
  • FDA 510K Classification: BK170096.

All necessary regulatory documentation, instructions for use, published studies, patient education tools, etc. (as applicable) can be provided upon request by contacting or (888) 240-8091. We are available at any time to meet with Providers and Staff to answer any questions about Spartan Medical’s entire portfolio of advanced medical solutions.